HeartSciences
HSCS | NASDAQ
$2.08
-$0.04 (-2.12%)
At close: Nov 16, 2026, 4:00 PM ET
$2.03
-$0.05 (-2.40%)
After-hours:
Nov 16, 2026, 4:31 PM ET
-2.12%
(1D)No price chart data available for 1D timeframe.
Rating
40.5
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #518/1021 (Top 51%)
Key Statistics
Market Data
Market Cap $10.34M
1D Range
2.05 2.18
52W Range
1.67 5.20
Valuation (TTM)
PE -0.65
PB -5.08
EV/EBITDA 1.67
Valuation (NTM)
Forward PE N/A
Forward PEG 0.02
Price Target $3.00
Cash Flow
FCF Yield -66.1%
SBC Adj. FCF Yield -84.3%
SBC Impact -27.5%
Margins
Gross Margin -2908.8%
Operating Margin -209733.1%
FCF Margin -151268.8%
Growth (CAGR)
Revenue 3Y | 5Y 32.3% |
-27.4%
Dil EPS 3Y | 5Y 88.6% |
71.0%
FCF 3Y | 5Y -0.2% |
1.4%
Returns
ROA -274.5%
ROE -816.3%
ROIC -480.8%
Financial Health
Net Cash
$26.18M
Current Ratio 0.12
Interest Coverage -11.78
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ...
Sector Healthcare
Industry Medical - Devices
Employees 14
IPO Date Jun 16, 2022
Website heartsciences.com
Fiscal Year May - April
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$3.00
Upside
+44.23%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove HSCS